2024 annual financial data

Sutro Biopharma 2024 Net margin

Direct answer

Net margin was -366.62%.

Operating income was -238.45M USD and net income was -227.46M USD.
Operating cash flow was -191.54M USD.

Get free Sutro Biopharma email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
62.04M USD
Operating income
-238.45M USD
Net income
-227.46M USD
Operating cash flow
-191.54M USD